Please note that new group has been formed to discuss subjects related to
the regulation of drugs, biologics and medical devices. This group
<alt.pharm.reg-affairs> has been created to enhance the dissemination of
information concerning the regulation of pharmaceutical products by
various government agencies – such as the US Food and Drug Administration
(FDA), The European Agency for the Evaluation of Medicinal Products
(EMEA), and the Japanese Ministry of Health and Welfare (MHW). While
this group was formed by regulatory professionals primarily for the use
by others in industry and government, the general public is welcome to
post questions in this forum.
–
Les Thomas
XOMA Corporation – Department of Regulatory Affairs
ltho…@sirius.com
- Hide quoted text — Show quoted text -
Les Thomas <ltho…@sirius.com> wrote:
>Please note that new group has been formed to discuss subjects related to
>the regulation of drugs, biologics and medical devices. This group
><alt.pharm.reg-affairs> has been created to enhance the dissemination of
>information concerning the regulation of pharmaceutical products by
>various government agencies – such as the US Food and Drug Administration
>(FDA), The European Agency for the Evaluation of Medicinal Products
>(EMEA), and the Japanese Ministry of Health and Welfare (MHW). While
>this group was formed by regulatory professionals primarily for the use
>by others in industry and government, the general public is welcome to
>post questions in this forum.
>–
>Les Thomas
>XOMA Corporation – Department of Regulatory Affairs
>ltho…@sirius.com
Les,
Great to hear something like this has been set up. I don’t have it yet
on my service providers newsfeed but i’m sure I will soon.
I am in Regulatory with Zeneca pharmaceuticals myself and am finding
the Internet incresingly useful in my job – especially with EMEA
coming on board with a Web presence and beginning to post public
assessment reports for drugs which have gone through the new
centralised filing procedure there.
Things which I would be keen to hear people’s views on are:
1) Where is ICH inititaive on electronic data transfers going
2) Hypertext as a new authoring adjunct and good style re its use in
electronic submissions
3) Acobat PDF vs SGML vs HTML as a common currency for exchange of
electronic regulatory documentation
4) electronic doc mgt systems, opinions Documentum vs others
Ricky Bache, Macclesfield, Cheshire
England
E Mail: bac…@dircon.co.uk